Table 2.
Number of PET-CT scans (N = 43) | % | |
---|---|---|
Indication for PET/CTa | ||
diagnosis (without prior biopsy) | 2 | 4.7 |
staging | 20 | 46.5 |
primary staging | 2 | |
re-staging after therapyb | 18 | |
interval monitoring | 3 | |
residual tumor & vitality | 5 | |
therapy response | 11 | |
suspected recurrencec d | 21 | 48.8 |
new lesion in preceding imaging | 17 | |
laboratory & tumor markers | 10 |
CCA, Cholangiocarcinoma.
PET/CT indications: diagnosis (suspected primary), staging (primary staging and re-staging after therapy of histologically confirmed cancer), and suspected recurrence of previously treated cancer
of 18 cases re-staging after last documented therapy: 13 cases during/after chemotherapy, two cases after (re-) surgery, two cases after TACE, and one case after radiation therapy
of 21 cases with suspected recurrence (last documented therapy): 19 cases after chemotherapy, one case after re-surgery, and one case after radiation therapy
multiple selection possible